.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Medtronic
Fuji
Johnson and Johnson
Farmers Insurance
Cipla
US Department of Justice
AstraZeneca
Baxter
Chubb

Generated: September 20, 2017

DrugPatentWatch Database Preview

TESSALON Drug Profile

« Back to Dashboard

Which patents cover Tessalon, and when can generic versions of Tessalon launch?

Tessalon is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in TESSALON is benzonatate. There are six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the benzonatate profile page.

Summary for Tradename: TESSALON

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list18
Patent Applications: see list1,079
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TESSALON at DailyMed

Pharmacology for Tradename: TESSALON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TESSALON
benzonatate
CAPSULE;ORAL011210-001Approved Prior to Jan 1, 1982AARXYesNo► Subscribe► Subscribe► Subscribe
Pfizer
TESSALON
benzonatate
CAPSULE;ORAL011210-003Jun 25, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fuji
Federal Trade Commission
Fish and Richardson
Harvard Business School
McKinsey
Chubb
Queensland Health
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot